Lucis Raises $20 Million Series A to Scale AI-Driven Preventive…

Team S · 2026-05-26T14:56:41.000Z

French preventive healthcare startup Lucis has secured $20 million in Series A funding to accelerate expansion of its AI-powered preventive health platform across Europe. The round was led by Singular, with participation from General Catalyst, Y Combinator, and several strategic angel investors. Founded by Maxime Berthelot and Baptiste Debever, Lucis combines advanced blood biomarker testing, longitudinal health analysis, and AI-powered diagnostics to help users proactively monitor health risks before symptoms appear. The platform analyzes more than 110 biomarkers and delivers personalized health insights reviewed by medical professionals. The company stated that the fresh capital will support European expansion, scaling of its AI infrastructure, laboratory partnerships, physician network growth, and product development focused on preventive healthcare intelligence. Lucis is positioning itself as a “preventive health operating system” built around continuous health monitoring and AI-assisted personalized medicine. According to the company, Lucis has already completed more than 500,000 clinical tests and expanded operations across France, the UK, Ireland, and Portugal within its first year. The startup says its AI systems are trained on large-scale biomarker datasets to generate actionable health recommendations and early risk detection signals. The funding highlights growing investor interest in AI-driven preventive healthcare, personalized diagnostics, longevity technology, and digital health infrastructure as healthcare systems increasingly shift toward proactive care models instead of reactive treatment.

Member Login Get Access

Lucis Raises $20 Million Series A to Scale AI-Driven Preventive… | Newnex